Han-Bin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Han-Bin Zhao has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Guang-Zhao Wang
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publication- Shi-Qi Wang
Department of Cancer Diagnosis and Treatment Center, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan 450046, China
1 shared publication Wan-Yu Ba
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publicationWen-Bo Zhu
The First Clinical Medical College of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publicationZu-Long Wang
Department of Andrology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan, China
1 shared publication
Latest Publications
- Open Access
- 31 January 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Advances in the diagnosis and treatment of oligoasthenozoospermia based on epigenetic regulation
Male infertility accounts for a substantial proportion of global infertility, yet its molecular basis remains incompletely defined. Emerging evidence implicates epigenetic dysregulation in impaired spermatogenesis and abnormal sperm function. We synthesize genomic, transcriptomic, and single-cell studies to clarify how DNA methylation, histone modifications, and noncoding RNAs contribute to oligoasthenozoospermia. We also appraise single-cell RNA sequencing, single-cell assay for transposase-accessible chromatin using sequencing, and integrative multi-omics for resolving cell-type and stage-specific regulation. These approaches resolve germ-cell lineages, map gene-regulatory networks, and link chromatin states with transcription across spermatogenesis. Finally, we discuss translational implications for diagnostics, biomarkers, and therapeutic strategies, including antioxidant regimens, varicocele management, and assisted reproductive technologies outcomes. In conclusion, integrating epigenetics with single-cell technologies has enhanced our understanding of male germ cell development and identified potential research directions to improve reproductive health.
- 31 January 2026
- Published by SAGE Publications in Therapeutic Advances in Urology
- Vol. 18
Open AccessAdvances in the diagnosis and treatment of oligoasthenozoospermia based on epigenetic regulation
Male infertility accounts for a substantial proportion of global infertility, yet its molecular basis remains incompletely defined. Emerging evidence implicates epigenetic dysregulation in impaired spermatogenesis and abnormal sperm function. We synthesize genomic, transcriptomic, and single-cell studies to clarify how DNA methylation, histone modifications, and noncoding RNAs contribute to oligoasthenozoospermia. We also appraise single-cell RNA sequencing, single-cell assay for transposase-accessible chromatin using sequencing, and integrative multi-omics for resolving cell-type and stage-specific regulation. These approaches resolve germ-cell lineages, map gene-regulatory networks, and link chromatin states with transcription across spermatogenesis. Finally, we discuss translational implications for diagnostics, biomarkers, and therapeutic strategies, including antioxidant regimens, varicocele management, and assisted reproductive technologies outcomes. In conclusion, integrating epigenetics with single-cell technologies has enhanced our understanding of male germ cell development and identified potential research directions to improve reproductive health.